Leukemia Gene Therapy: Curing an Incurable Blood Cancer
Here’s a breakdown of the T-cell therapy described in the text, focusing on how it avoids self-destruction and works to fight cancer:
The Problem:
Customary T-cell therapies (like CAR-T cell therapy) can be incredibly effective against cancer, but they also carry a risk of the treatment attacking healthy cells, or even the modified T-cells attacking each other. This is because the modified T-cells still express markers that can trigger an immune response.
The Solution – Genetic Modifications:
Researchers used a series of genetic modifications to overcome thes challenges:
- Disable Targeting: The initial targeting mechanism of the T-cells was disabled to prevent them from promptly attacking the patient’s body.
- Remove CD7 Marker: A chemical marker called CD7, present on all T-cells, was removed from the modified T-cells. This is crucial because the modified cells are programmed to attack cells with the CD7 marker. Removing it prevents the treatment from destroying itself.
- “Invisibility Cloak”: The modified T-cells were given a genetic modification that protected them from being killed by a specific chemical drug. This further shields them from the patient’s immune system.
- Programmed to Attack CD7+ Cells: the T-cells were programmed to specifically seek out and destroy any cell that still displays the CD7 marker – meaning any remaining cancerous T-cells or healthy T-cells that haven’t been modified.
How it effectively works in Practice:
* Injection: The modified T-cells are injected into the patient.
* Cancer Destruction: They hunt down and eliminate T-cells displaying the CD7 marker.
* Immune System Reset: If no cancer is detected after four weeks, the patient receives a bone marrow transplant to rebuild their immune system from scratch.This is necessary because the treatment essentially wipes out the existing immune system.
Key Takeaway:
The cleverness of this therapy lies in its ability to create modified T-cells that can aggressively target cancer while simultaneously protecting themselves from being destroyed by the patient’s own immune system or by each other.